Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|August 31, 2016
The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel DiseaseM Severs, B Oldenburg, A A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Distribution of mesalazine enemas in active and quiescent ulcerative colitisA A van Bodegraven, R O Boer, J Lourens, et al.
Scandinavian Journal of Gastroenterology|June 1, 1995
Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel diseaseA A Van Bodegraven, H A Tuynman, M Schoorl, et al.
The Netherlands Journal of Medicine|November 6, 1998
Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotideA A van de Loosdrecht, A A van Bodegraven, J M Sepers, et al.
International Journal of Immunogenetics|November 30, 2005
A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitisM E A Borm, A A van Bodegraven, C J J Mulder, et al.
Genes and Immunity|March 15, 2008
The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotypeM E A Borm, A A van Bodegraven, C J J Mulder, et al.
Frontline Gastroenterology|August 26, 2017
Refractory diversion neovaginitis in a sigmoid-colon-derived neovagina: clinical and histopathological considerationsW B van der Sluis, M Bouman, Wjhj Meijerink, et al.
Clinical Chemistry and Laboratory Medicine|October 12, 2000
Serum eosinophil cationic protein in active and quiescent ulcerative colitisC J Pronk-Admiraal, R K Linskens, A A Van Bodegraven, et al.
Clinical and Experimental Immunology|February 28, 2003
Signal transducer and activator of transcription 6 gene G2964A polymorphism and inflammatory bowel diseaseB Xia, J B A Crusius, J Wu, et al.
Journal of Intensive Care Medicine|April 6, 2011
Assessment of small bowel function in critical illness: potential role of citrulline metabolismJ H C Peters, A Beishuizen, M B Keur, et al.
Pageof 7